Literature DB >> 25913296

Supplemental morphine infusion into the posterior ventral tegmentum extends the satiating effects of self-administered intravenous heroin.

S Steidl1, S Myal2, R A Wise2.   

Abstract

Rats learn to self-administer intravenous heroin; well-trained animals lever-press at a slow and regular pace over a wide range of intravenous doses. The pauses between successive earned infusions are proportional to the dose of the previous injection and are thought to reflect periods of drug satiety. Rats will also self-administer opiates by microinjection directly into sites in the posterior regions of the ventral tegmentum. To determine if the pauses between self-administered intravenous injections are due to opiate actions in posterior ventral tegmentum, we delivered supplemental morphine directly into this region during intravenous self-administration sessions in well-trained rats. Reverse dialysis of morphine into the posterior ventral tegmentum increased the intervals between earned injections. The inter-response intervals were greatest for infusion into the most posterior ventral tegmental sites, sites in a region variously known as the tail of the ventral tegmental area or as the rostromedial tegmental nucleus. These sites at which morphine prolongs inter-response intervals, correspond to the sites at which opiates have been found most effective in reinforcing instrumental behavior. Published by Elsevier Inc.

Entities:  

Keywords:  Anterior VTA; Cocaine; Drug reinforcement; Drug satiety; Microdialysis

Mesh:

Substances:

Year:  2015        PMID: 25913296      PMCID: PMC4457578          DOI: 10.1016/j.pbb.2015.04.006

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  26 in total

1.  Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse.

Authors:  Salvatore Lecca; Miriam Melis; Antonio Luchicchi; Anna Lisa Muntoni; Marco Pistis
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  Opioids excite dopamine neurons by hyperpolarization of local interneurons.

Authors:  S W Johnson; R A North
Journal:  J Neurosci       Date:  1992-02       Impact factor: 6.167

3.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1964

4.  Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat.

Authors:  H Welzl; G Kuhn; J P Huston
Journal:  Neuropharmacology       Date:  1989-10       Impact factor: 5.250

5.  DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment.

Authors:  Linda I Perrotti; Carlos A Bolaños; Kwang-Ho Choi; Scott J Russo; Scott Edwards; Paula G Ulery; Deanna L Wallace; David W Self; Eric J Nestler; Michel Barrot
Journal:  Eur J Neurosci       Date:  2005-05       Impact factor: 3.386

6.  Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons.

Authors:  Aya Matsui; John T Williams
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

7.  Satiating effects of cocaine are controlled by dopamine actions in the nucleus accumbens core.

Authors:  Nobuyoshi Suto; Roy A Wise
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

8.  Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat.

Authors:  Laura M Borland; Guoyue Shi; Hua Yang; Adrian C Michael
Journal:  J Neurosci Methods       Date:  2005-03-05       Impact factor: 2.390

9.  The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses.

Authors:  Thomas C Jhou; Howard L Fields; Mark G Baxter; Clifford B Saper; Peter C Holland
Journal:  Neuron       Date:  2009-03-12       Impact factor: 17.173

10.  Control of within-binge cocaine-seeking by dopamine and glutamate in the core of nucleus accumbens.

Authors:  Nobuyoshi Suto; Laurel E Ecke; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2009-05-13       Impact factor: 4.530

View more
  6 in total

Review 1.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

Review 2.  Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

Authors:  Chloe J Jordan; Jianjing Cao; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-19       Impact factor: 5.250

3.  Dissecting the Role of GABA Neurons in the VTA versus SNr in Opioid Reward.

Authors:  Ewa Galaj; Xiao Han; Hui Shen; Chloe J Jordan; Yi He; Bree Humburg; Guo-Hua Bi; Zheng-Xiong Xi
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

4.  Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.

Authors:  Adam Kimbrough; Jenni Kononoff; Sierra Simpson; Marsida Kallupi; Sharona Sedighim; Kenia Palomino; Dana Conlisk; Jeremiah D Momper; Giordano de Guglielmo; Olivier George
Journal:  Psychopharmacology (Berl)       Date:  2020-02-29       Impact factor: 4.530

Review 5.  Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation.

Authors:  Laura G Rosen; Ninglei Sun; Walter Rushlow; Steven R Laviolette
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

Review 6.  Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.

Authors:  Ewa Galaj; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2020-05-03       Impact factor: 8.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.